Navigation Links
EastBridge Investment Group Announces Completion of its Merger with Cellular Biomedicine Group - Shareholder Conference Call to be held February 8th
Date:2/7/2013

PHOENIX, Feb. 7, 2013 /PRNewswire/ --EastBridge Investment Group Corporation (EBIG), a provider of financial consulting services to companies in Asia and the United States ("EBIG"), today announced that on February 6, EBIG and Cellular Biomedicine Group ("CBMG") executed all documentation and filed the Articles of Merger with the Registry of Corporate Affairs of the British Virgin Islands with respect to the consummation of the merger of CBMG with CBMG Acquisition Limited, a wholly-owned subsidiary of EBIG. The merged company is a wholly-owned subsidiary of EBIG.  EBIG continues to operate under the corporate name "EastBridge Investment Group Corporation", a Delaware corporation, and its common stock continues to be quoted on the OTCQB under stock symbol "EBIGD".  

A shareholder conference call is scheduled for February 8, 2013, at 11:00am EST, for questions and answers with the new corporate management team of EastBridge. Dial-in numbers for both domestic and international calls are listed below. You may also listen to a replay of the conference call by dialing the appropriate number and access code below. A replay of the conference call will be available on the company's website following the call.

Participants Dial-In Numbers

Toll-Free (US & Canada) (888) 390-3983

International (201) 604-5105

Dialing In For Conference Recording Playback

1. Dial 888-632-8973, or 585-295-6791 if you are calling from outside the USA.

2. At the system prompt, dial your replay code (80529152) followed by the # sign.

About Cellular Biomedicine Group
Cellular Biomedicine Group, Ltd. develops proprietary cell therapies for
'/>"/>

SOURCE EastBridge Investment Group Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. EastBridge Investment Group and CBMG attended SeeThruEquity Investor Conference in New York
2. Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
3. Axela Inc. Retains Investment Bank to Evaluate Strategic Opportunities
4. Analysis of Venture Capital Investment Trends in the North American and European Healthcare Industry
5. Kansas Bioscience Authority Approves $700,000 in Investments
6. David Lichtenstein: Biotechnology is Rich Area for Investment
7. Israeli Ministry of Finance Hosts Israel Investment, Innovation and Trade Forum in New York
8. Foundation Venture Capital Group Makes Eighth Start-Up Investment
9. Regenerative Sciences Receives $2M Investment for Orthopedic Stem Cell Initiatives
10. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
11. City of Mason and Top Gun Sales Performance Announce $4 Million Investment In New Corporate Headquarters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... RMI specializes in Stemnexa™ ... such as meniscal tears, ACL injuries, rotator cuff ... due to degenerative conditions like osteoarthritis. Stemnexa ... promote better post-surgical outcomes. , Stemnexa combines the ... marrow harvesting with two complimentary cellular technologies: Bone ...
(Date:3/4/2015)... SANTA BARBARA, CALIFORNIA (PRWEB) March 04, 2015 ... regulatory consulting firm in the life sciences industry, hired ... Compliance. Blewitt leads the Cloud Compliance Services and ... sciences companies utilize cloud based applications while maintaining compliance ... 20 years, Blewitt has been an accomplished life sciences ...
(Date:3/4/2015)... Proove Biosciences , a commercial ... to announce the launch of their CME-accredited course ... of Pain”. , The continuing medical education program ... year. The focus of the program is to ... treatments, integrate appropriate pain management techniques, and incorporate ...
(Date:3/4/2015)... 2015 Launched by the ... in December 2011, ,SARAH, - the French ... versus sorafenib in advanced hepatocellular carcinoma (HCC) has enrolled ... SARAH, a large French study of patients ... HCC) has completed patient enrolment, exceeding its 400-patient target, ...
Breaking Biology Technology:Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 4Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 5USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 3Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5
... LOS ANGELES, Oct. 13 Vista Partners announced ... Bio Medica Corporation,(Nasdaq: ABMC ) and maintains ... Director of Research at Vista Partners stated, "Sales,internationally ... lab,alliance, which give ABMC,s products exposure in numerous ...
... Houston-based Proximity Systems ... WorkStations: one year ... installing 400,Proximity Systems Computer WorkStations, Centerpoint Medical Center offers,favorable ... workstations are satisfying the needs of the,hospital,s nurses, physicians, ...
... October 13 The International Diabetes,Federation (IDF) announced today ... for action to secure care for the thousands of ... The meeting, Access to Essential Diabetes Medicines for ... October 25 in London, United,Kingdom. The International Diabetes Federation ...
Cached Biology Technology:Vista Partners Updates Coverage; Maintains $3.20 Target Price 2In-Room Computers and Wall-Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency; Improved Patient Care 2In-Room Computers and Wall-Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency; Improved Patient Care 3In-Room Computers and Wall-Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency; Improved Patient Care 4International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 2International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 3
(Date:2/5/2015)... North Carolina , 5. Februar 2015 ... Jahr als spezialisiertes Logistikunternehmen und hat eine ... einzige klinische Logistikfirma (Clinical Logistics Organization – ... der neuen Kampagne lautet First , ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... 2015   Epic Sciences , a precision diagnostics company ... Murali Prahalad , Ph.D., president and CEO, is scheduled ... (PMWC) 2015: Silicon Valley, which is taking place at the ... on January 26-28, 2015. Dr. Prahalad ... Biomarkers." Last year, Epic Sciences was a finalist in the ...
(Date:2/5/2015)... , Jan. 27, 2015   ... of globally deployed, innovative test solutions for ... the delivery of its TS-323 GENASYS ... Systems Company (LMSSC). GENASYS is a high-performance ... of mission-critical applications that require performance functional ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... that certain genes can influence a person,s likelihood to ... the Masonic Cancer Center, University of Minnesota demonstrates that ... survive the disease. ... has successfully identified combinations of genes associated with early ...
... French . Maputo, MozambiqueThe ... research programme designed to understand the relationship between ... services. The decision was made today at the ... (ICSU) and should help provide the scientific knowledge ...
... Evolved Machines, Inc. has,been selected as ... Advanced Research,Projects Agency (DARPA) program to engineer ... recognition. The $5.1 million,dollar contract will integrate ... a highly versatile and sensitive broad-spectrum device ...
Cached Biology News:U of MN study shows link between gene variations and cancer survival 2ICSU launches new program to understand the human impact on Earth's life-support systems 2
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (R3776) ... assistance. Material: cap polystyrene ...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
... Yeast Display Vector is specifically designed to ... surface of Saccharomyces cerevisiae. Displayed proteins can ... with known or putative ligands. pYD1 uses ... of two domains, Aga1 and Aga2, to ...
... pump series combines Harvard Apparatuss best pump mechanism, ... wide range of configuration options. A lookup table ... syringes from all the major manufacturers. A bright, ... pertinent information from across the lab. All models ...
Biology Products: